Archive for April 2018

Linda Armstrong has led the Global Respiratory Development Unit at Novartis Pharmaceutical Co. since November 1, 2016. Prior to this role, she was the CMO and Head of Medical Affairs for the Novartis Cell & Gene Therapies Unit. Linda has had jobs of increasing responsibility in Clinical Development, Patient Safety and Medical Affairs, supporting numerous…

Chau Quang Khuong is Partner in the Private Equity group at OrbiMed Advisors, a global healthcare-dedicated investment firm with approximately $15 billion in assets under management. During his investment career, Mr. Khuong has been actively involved in innovative drug development and medical device enterprises across all stages and therapeutic areas including respiratory, oncology, infectious diseases,…

Onaiza Cadoret Manier is an international commercialization and operations executive with 25 years driving growth for Fortune 500 and start-up companies—Genentech, Pfizer, and Amylin Pharmaceuticals. She is recognized for strategic and inspirational leadership, launching new products, and reviving landmark brands across multiple therapeutic areas. Onaiza has been at Genentech since 2011 leading and building the…

A follower and fan of medtech for nearly two decades, Tom Salemi is the former Bureau Chief, Venture Capital, at Elsevier Business Intelligence, where he oversaw coverage of venture investments in medtech. Prior to working at Elsevier, he served as Senior Staff Writer at Windhover Information and news editor at Dow Jones where he edited…

For the past 20 years, Glen has focused on the development and commercialization of technologies to address the unmet needs of patients with severe lung diseases. He has co-founded, built and sold three medical device companies. Pulmonx develops and markets minimally invasive technologies for the diagnosis and treatment of patients with severe emphysema. Prior to…

Ted Omachi is a Medical Director in the Product Development Immunology group at Genentech, focusing on late-stage development in respiratory and allergic diseases. He joined Genentech in 2013, starting in the Medical Affairs group before transitioning to Product Development in 2015. At Genentech, he has served as Clinical Science Team Leader, Medical Monitor and Medical…

Sally Seymour received a medical degree from the University of Cincinnati. She did her internship and residency training in internal medicine and fellowship training in pulmonary and critical care medicine at the University of Cincinnati. She joined the FDA as a Medical Officer in 2003. She is currently the Deputy Director for Safety in the…